LUNSUMIO

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug LUNSUMIO contains one active pharmaceutical ingredient (API):

1 Mosunetuzumab UNII LDJ89SS0YG - MOSUNETUZUMAB

Mosunetuzumab is an anti-CD20/CD3 T-cell engaging bispecific antibody targeting CD20-expressing B-cells. It is a conditional agonist; targeted B-cell killing is observed only upon simultaneous binding to CD20 on B-cells and CD3 on T-cells. Engagement of both arms of mosunetuzumab results in the formation of an immunologic synapse between a target B cell and a cytotoxic T cell leading to T-cell activation. Subsequent directed release of perforin and granzymes from T-cell activation through the immunologic synapsis induce B-cell lysis leading to cell death. Read about Mosunetuzumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUNSUMIO Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XC	† Monoclonal antibodies	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents
Discover more medicines within L01XC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1885259, 1885260
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 481789, 511433
Country: FR	Base de données publique des médicaments	Identifier(s): 64119565, 64499808
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9222, 9436
Country: IT	Agenzia del Farmaco	Identifier(s): 050151012, 050151024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1094946, 1094947
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68902001, W68903001
Country: US	FDA, National Drug Code	Identifier(s): 50242-142, 50242-159